Abstract
BACKGROUND AKT pathway activation is implicated in endocrine-therapy resistance. Data on the efficacy and safety of the AKT inhibitor capivasertib, as......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
